G. Papeo et al.
(5S)-2,2,8-Trimethyl-2,5-dihydro-1-benzoxepine-5-carbaldehyde 33.7 (CH2CH), 39.3 (CH3CH), 80.2 [(CH3)2C], 125.0 (ArCH),
FULL PAPER
(14): TiCl3 (57.5 mg, 0.373 mmol) was dissolved in DME (2.5 mL)
under an inert atmosphere, LiAlH4 (7 mg, 0.184 mmol) was added
and the suspension was heated to reflux for 20 min. A solution of
4 (20 mg, 0.081 mmol) in DME (3 mL) was then added by syringe-
pump (flow: 0.009 mL/ min) under reflux. The reaction was moni-
tored by TLC (hexane/AcOEt = 95:5). When the addition of 4 was
complete, the reaction mixture was heated to reflux for a further
17 h before being filtered through a pad of Celite and concentrated
to dryness. Flash chromatography (hexane/AcOEt = 98:2) allowed
126.6 (ArCH), 129.8 (CCH=CHCH2), 130.5 (ArCH), 134.8
(ArCCH3), 134.9 (CCH=CHCH2), 136.5 (ArCCH), 152.3
(ArCO) ppm. HRMS (ESI+): calcd. for C15H21O [M + H]+
217.1587; found 217.1580.
(S)-(+)-7,11-Helianane (1): Alkene 13 (16 mg, 0.074 mmol), dis-
solved in MeOH (11 mL), was hydrogenated in the presence of 5
wt.-% Pd/C (10 mg) at 30 psi for 5 h. The catalyst was filtered
through a pad of Celite, and (S)-(+)-7,11-helianane (1; 14 mg, 87%)
was recovered as a colorless oil after flash chromatography (hexane/
AcOEt = 100:1). [α]D = +18.9 (c = 0.59, CH2Cl2). 80%ee (Chiral
HPLC; column: Phenomenex Lux Amylose-2, 4.6ϫ250 mm, 5 μm;
eluent: H2O/CH3CN = 60:40 isocratic; flow: 0.8 mL/min; detector:
1
the isolation of pure 14 as a colorless oil (11 mg, 63%). H NMR
(400.5 MHz, [D6]DMSO, 28 °C): δ = 1.23 (s, 3 H, CH3CCH3), 1.30
(d, J = 7.1 Hz, 3 H, CH3CH), 1.59 (s, 3 H, CH3CCH3), 2.24 (s, 3
H, ArCH3), 3.72 (q, J = 7.1 Hz, 1 H, CHCH3), 6.63 (s, 1 H, CH=),
6.80 (br. s, 1 H, ArCH), 6.83 (br. d, J = 7.9 Hz, 1 H, ArCH), 7.03
(d, J = 7.9 Hz, 1 H, ArCH), 9.34 (s, 1 H, CHO) ppm. 13C NMR
(125.7 MHz, [D6]DMSO, 25 °C): δ = 19.8 (CH3Ar), 21.1 (CH3CH),
24.6 (CH3CCH3), 28.6 (CH3CCH3), 33.0 (CHCH3), 77.8
[(CH3)2C], 124.1 (ArCH), 124.1 (ArCH), 128.5 (ArCH), 135.3
(ArCCH), 136.8 (ArCCH3), 141.3, (CH=C), 152.9 (ArCO), 157.3
(CH=), 193.7 (CHO) ppm. HRMS (ESI+): calcd. for C14H17O2 [M
+ H]+ 217.1223; found 217.1218.
1
UV 220 nm). H NMR (499.7 MHz, CDCl3, 50 °C): δ = 1.25 (d, J
= 7.1 Hz, 3 H, CH3CH), 1.28 (s, 3 H, CH3CCH3), 1.40 (s, 3 H,
CH3CCH3), 1.35–1.39 (m, 1 H, CHCH2CH2CHHC), 1.40–1.46 (m,
2 H , C H C H H C H H C H 2 C ) , 1 . 5 0 – 1 . 5 5 ( m , 1 H ,
CHCH2CH2CHHC), 1.56–1.63 (m, 1 H, CHCH2CHHCH2C),
1.70–1.78 (m, 1 H, CHCHHCH2CH2C), 2.27 (s, 3 H, ArCH3),
3.14–3.21 (m, 1 H, CHCH3), 6.70 (br. s, 1 H, ArCH), 6.87 (d, J =
7.0 Hz, 1 H, ArCH), 7.05 (d, J = 7.0 Hz, 1 H, ArCH) ppm. 13C
NMR (125.7 MHz, [D6]DMSO, 50 °C): δ = 21.0 (CH3Ar), 21.3
(CH3CH), 21.9 (CHCH2CH2CH2C), 26.9 (CH3CCH3), 29.3
(CH3CCH3), 31.7 (CHCH3), 38.2 (CHCH2CH2CH2C), 39.5
(CHCH2CH2CH2C), 80.8 [(CH3)2C], 124.7 (ArCH), 126.1 (ArCH),
126.1 (ArCH), 134.9 (ArCCH3 ), 138.5 (ArCCH), 152.7
(ArCO) ppm. HRMS (ESI+): calcd. for C15H22ONa [M + Na]+
241.1568; found 241.1571.
2-Methylbut-3-en-2-yl 5-Methyl-2-[(2S)-pent-4-en-2-yl]phenyl Ether
(15): A solution of 4 (91 mg, 0.367 mmol) and Petasis reagent
(Cp2TiMe2; 10.7 wt.-% in THF/toluene, 4.26 g, 2.19 mmol) in an-
hydrous THF (1.5 mL) was irradiated in a microwave reactor at
100 °C for 15 min. Hexane was then added and the mixture was
stirred for 1 h. The resulting white precipitate was filtered off and
the mother liquor was taken to dryness under reduce pressure.
Diene 15 was purified by flash chromatography (hexane/AcOEt =
100:1) and isolated as a colorless oil (44 mg, 50 %). 1H NMR
(499.7 MHz, [D6]DMSO, 25 °C): δ = 1.10 (d, J = 6.9 Hz, 3 H,
CH3CH), 1.41 [s, 6 H, (CH3)2C], 2.18 (s, 3 H, ArCH3), 2.16–2.31
(m, 2 H, CH2CH), 3.12–3.20 (m, 1 H, CHCH3), 4.90–4.93 (m, 1
H, CH2CH=CHcis), 4.94–5.00 (m, 1 H, CH2CH=CHtrans), 5.15 (dd,
J = 10.8, 1.1 Hz, 1 H, CCH=CHcis), 5.22 (dd, J = 17.6, 1.1 Hz, 1
H, CCH=CHtrans), 5.62–5.75 (m, 1 H, CH2CH=CH), 6.12 (dd, J
= 17.66, 10.8 Hz, 1 H, CCH=CH), 6.71 (br. d, J = 7.6 Hz, 1 H,
ArCH), 6.80 (s, 1 H, ArCH), 7.03 (d, J = 7.6 Hz, 1 H, ArCH) ppm.
13C NMR (125.7 MHz, [D6]DMSO, 25 °C): δ = 20.1 (CH3CH),
20.7 (CH3Ar), 27.1 [(CH3)2C], 31.3 (CHCH3), 40.9 (CH2CH), 79.0
[(CH3)2C], 112.7 (CCH=CH2), 115.6 (CH2CH=CH2), 119.1
(ArCH), 121.7 (ArCH), 126.2 (ArCH), 134.9 (ArCCH), 135.3
(ArCCH3), 137.4 (CH2CH=CH2), 144.2 (CCH=CH2), 153.2
(ArCO) ppm. HRMS (ESI+): calcd. for C17H25O [M + H]+
245.1900; found 245.1896.
(S)-(+)-5-Chloro-7,11-helianane (3): A solution of (S)-(+)-7,11-heli-
anane (1; 8 mg, 0.0366 mmol) and NCS (5.7 mg, 0.0366 mmol) in
anhydrous CH3CN (1 mL) was heated at 50 °C for 3.5 h [the reac-
tion was monitored by TLC (hexane)]. After removal of the solvent
under reduced pressure, purification by flash chromatography (hex-
ane/AcOEt = 100:1) afforded 3 as a colorless oil (7.9 mg, 85%).
[α]D = +33.4 (c = 0.36, CHCl3). 80%ee (Chiral HPLC; column:
Phenomenex Lux Amylose-2, 4.6ϫ250 mm, 5 μm; eluent: H2O/
CH3CN = 50:50 isocratic; flow: 1 mL/min; detector: UV 220 nm).
1H NMR (499.7 MHz, CDCl3, 25 °C):
(d, J = 7.1 Hz, 3 H, CH3CH), 1.27 (s, 3 H, CH3CCH3), 1.39 (s, 3
H, CH3CCH3), 1.35–1.39 (m, H, CHCH2CH2CHHC),
δ
=
1.24
1
1.40–1.46 (m, 2 H, CHCHHCHHCH2C), 1.50–1.55 (m, 1 H,
CHCH2CH2CHHC), 1.56–1.63 (m, 1 H, CHCH2CHHCH2C),
1.72–1.77 (m, 1 H, CHCHHCH2CH2C), 2.28 (s, 3 H, ArCH3),
3.11–3.17 (m, 1 H, CHCH3), 6.74 (br. s, 1 H, ArCH), 7.11 (s, 1 H,
ArCH) ppm. 13C NMR (125.7 MHz, [D6]DMSO, 25 °C): δ = 19.3
(CH3Ar), 20.8 (CH3CH), 21.6 (CHCH2CH2CH2C), 26.3
(CH3CCH3),
29.2
(CH3CCH3),
31.9
(CHCH3),
37.9
(3Z,6S)-2,2,6,9-Tetramethyl-5,6-dihydro-2H-1-benzoxocine (13):
The second generation Grubbs catalyst (B; 8.8 mg, 0.01 mmol) was
charged in a two-necked round-bottomed flask under an inert at-
mosphere. A solution of 15 (24 mg, 0.098 mmol) in anhydrous de-
gassed CH2Cl2 (8 mL) was then added and the mixture was stirred
for 6 h [reaction monitored by TLC (hexane)]. After the disappear-
ance of the starting material, the solvent was removed in vacuo
and 13 was isolated by flash chromatography on silica gel (hexane/
AcOEt = 100:1) as a light-yellow oil (17 mg, 80 %). 1H NMR
(499.7 MHz, [D6]DMSO, 25 °C): δ = 1.13 (d, J = 6.7 Hz, 3 H,
CH3CH), 1.31 (s, 3 H, CH3CCH3), 1.51 (s, 3 H, CH3CCH3), 2.09
(br. s, 1 H, CHHCH), 2.21 (s, 3 H, ArCH3), 2.89 (br. s, 1 H,
CHCH3), 3.13 (br. s, 1 H, CHHCH), 5.22 (d, J = 10.8 Hz, 1 H,
CCH=CHCH2), 5.57–5.66 (m, 1 H, CCH=CHCH2), 6.68 (s, 1 H,
ArCH), 6.83 (br. d, J = 7.3 Hz, 1 H, ArCH), 6.96 (d, J = 7.3 Hz,
(CHCH2CH2CH2C), 39.2 (CHCH2CH2CH2C), 81.5 [(CH3)2C],
126.6 (ArCH), 127.1 (ArCH), 129.5 (ArCCl), 132.9 (ArCCH3),
141.3 (ArCCH), 151.7 (ArCO) ppm. HRMS (ESI+): calcd. for
C15H21ClONa [M + Na]+ 275.1173; found 275.1790.
Supporting Information (see footnote on the first page of this arti-
cle): Copies of the NMR spectra (1H, COSY, TROESY, gradient-
enhanced HSQC, and HMBC experiments) for compounds 1, 3, 5,
6, 11, 12, 13, and 14 described in this paper. Copies of chiral HPLC
spectra of compounds 1, 3, and 6. Experimental procedures for the
synthesis of Mosher’s esters of 5, diastereomeric amides of 11 (21),
and compound 20.
Acknowledgments
1 H, ArCH) ppm. 13C NMR (125.7 MHz, [D6]DMSO, 25 °C): δ = The authors like to thank Dr. Eduard Felder (Chemical Core Tech-
20.6 (CH3Ar), 25.2 (CH3CH), 28.2 (CH3CCH3), 29.3 (CH3CCH3), nologies, Department Head) and Dr. Daniele Donati (Medicinal
6800
www.eurjoc.org
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2011, 6794–6801